OSIMERTINIB-CDSS Precision Oncology
Transcriptomic Biomarker Classifier • 19-Gene EMT Matrix
Required Features: 19 Ensembl Genes
Drag & drop your patient RNA-Seq expression matrix
Upload normalized gene counts (TPM, FPKM, or CPM) with Ensembl Gene Identifiers
.CSV Format .TSV Format ENSG00000... IDs Single or Multi-Sample
Ready for clinical alignment
Pipeline Execution
Aligning 19-gene EMT transcriptomic signature...
Awaiting Patient Expression Matrix

Upload patient RNA-seq profiles or launch the sample demo cohort to predict risk of early progression on Osimertinib therapy based on the EMT transcriptomic signature.

Total Patients
0 analyzed samples
Biomarker Signature Coverage 0%
0% 19 EMT genes
High Risk / Early Progression
0 0% cohort
Durable Response / Low Risk
0 0% cohort

Individual Patient Risk Stratification

Guided Independent Study (GIS) Project
Lakshitha Nirmal Weragoda
Master of Science in Bioinformatics Student
Institute of Biochemistry, Molecular Biology and Biotechnology (IBMBB) • University of Colombo
IBMBB • University of Colombo MSc in Bioinformatics (GIS Project)